Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
3,145,310
-
Shares change
-
+12,656
-
Total reported value, excl. options
-
$14,311,158
-
Value change
-
+$1,348,464
-
Number of buys
-
19
-
Number of sells
-
-13
-
Price
-
$4.55
Significant Holders of PDS Biotechnology Corp - Common (PDSB) as of Q1 2021
36 filings reported holding PDSB - PDS Biotechnology Corp - Common as of Q1 2021.
PDS Biotechnology Corp - Common (PDSB) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,145,310 shares
of 49,594,356 outstanding shares and own 6.34% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (860,990 shares), RENAISSANCE TECHNOLOGIES LLC (667,747 shares), Ikarian Capital, LLC (383,373 shares), INSPIRION WEALTH ADVISORS, LLC (248,912 shares), GEODE CAPITAL MANAGEMENT, LLC (170,159 shares), FIRST MANHATTAN CO (149,067 shares), Sofinnova Investments, Inc. (142,635 shares), New Leaf Venture Partners, L.L.C. (117,242 shares), Minot Wealth Management LLC (45,439 shares), and MARSHALL WACE, LLP (44,232 shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.